Last reviewed · How we verify

NCT03568617

rTMS for the Prevention Treatment of CM: a Single Arm Study

Status unknown NA Last updated 26 June 2018
What this trial tests

NA trial testing rTMS in Chronic Migraine in 15 participants. Status unknown.

Timeline
30 June 2018
Primary endpoint
31 December 2021
30 June 2022

Quick facts

Lead sponsorPeking Union Medical College Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date30 June 2018
Primary completion31 December 2021
Estimated completion30 June 2022

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 65, any sex, with Chronic Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We design this pilot, single arm study to explore the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) for the treatment of chronic migraine. The hypothetical control group is pooled sham group in latest meta-analysis. We expect a significant improvement of the outcome measures during and after the treatment as compared to the hypothetical control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of rTMS

Trials testing the same drug.

Other recruiting trials for Chronic Migraine

Currently open trials in the same condition.

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03568617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing